ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,469.30
0.00%
Dow Jones
39,112.16
0.00%
US Dollar vs MXN
18.30109
0.96%
Brent Oil
84.34
0.18%
Bitcoin
61,548.65
-0.42%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Elutia Inc (ELUT)

  7. Elutia Inc (ELUT) Noticias

ELUT Elutia Inc

3.80
0.00 (0.00%)
Pre Mercado
Última actualización: 07:18:59
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Elutia Inc ELUT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 3.80 07:18:59
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.80
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
18/6/202415:15EDGAR2Form 8-K - Current report
17/6/202407:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/6/202407:15EDGAR2Form 8-K - Current report
17/6/202407:01GLOBEElutia Announces $13.26 Million Registered Direct Offering
17/6/202407:00GLOBEElutia Announces FDA Clearance of EluPro®: The First..
10/6/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202416:00EDGAR2Form 8-K - Current report
13/5/202416:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202407:00GLOBEElutia to Showcase BioEnvelope Product Line at Heart Rhythm..
09/5/202416:26EDGAR2Form 8-K - Current report
09/5/202415:05GLOBEElutia Announces First Quarter 2024 Results: SimpliDerm®..
02/5/202415:05GLOBEElutia to Report First Quarter 2024 Financial Results on..
24/4/202415:05GLOBEElutia to Present at the Planet MicroCap Showcase: VEGAS..
11/3/202408:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202415:24EDGAR2Form 8-K - Current report
07/3/202415:05GLOBEElutia Reports Fourth Quarter and Full Year 2023 Financial..
22/2/202415:05GLOBEElutia to Report Fourth Quarter and Full Year 2023 Financial..
14/2/202415:40EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/2/202415:30EDGAR2Form 8-K - Current report
25/1/202415:56EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/1/202416:00EDGAR2Form 8-K - Current report
10/1/202416:00EDGAR2Form 8-K - Current report
10/1/202415:05GLOBEElutia Regains Compliance with Nasdaq Listing Requirements
09/1/202415:17EDGAR2Form SC 13D/A - General statement of acquisition of..
08/1/202415:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202315:30EDGAR2Form 8-K - Current report
18/12/202307:00GLOBEElutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for..
08/12/202315:04EDGAR2Form 8-K - Current report
05/12/202315:54EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
04/12/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
20/11/202315:53EDGAR2Form S-3 - Registration statement under Securities Act of..
20/11/202315:02EDGAR2Form 8-K - Current report
15/11/202316:26EDGAR2Form 8-K - Current report
13/11/202315:05GLOBEElutia Reports 26% Year-Over-Year Sales Growth of..
09/11/202308:19EDGAR2Form 8-K - Current report
09/11/202307:30GLOBEElutia Completes Divestiture of Orthobiologics Business Unit..
07/11/202315:04EDGAR2Form 8-K - Current report
06/11/202315:05GLOBEElutia to Report Third Quarter 2023 Financial Results on..
18/10/202307:00PRNUSSWK Holdings Highlights Recent Achievements and Provides..
06/10/202314:28EDGAR2Form SC 13D/A - General statement of acquisition of..
05/10/202315:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202315:05EDGAR2Form 8-K - Current report
20/9/202307:30GLOBEElutia to Participate in a Panel Discussion at the Cantor..
19/9/202307:36GLOBEElutia Announces Private Placement for Proceeds Up to $26..
19/9/202307:30EDGAR2Form 8-K - Current report
18/9/202315:08GLOBEElutia Announces Sale of Orthobiologics Business Unit for..
08/9/202307:30GLOBEElutia to Present at the H.C. Wainwright 25th Annual Global..
06/9/202315:05GLOBEAziyo Biologics Rebrands as Elutia to Reflect Strategic..

Su Consulta Reciente

NASDAQ
ELUT
Elutia
LSE
BK55
Citi Fun 25
LSE
AK68
Citi Fun 24
USOTC
CYPXF
EQ (PK)
USOTC
BRLGF
Dominion Lending Centres (PK)
AQEU
INDAD
Lyxor Asset Management L...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados